Showing results 3 to 11 of 11
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2021 | 36 | |||
2020 | 64 | |||
Hypoxia inducible factor-1 (HIF-1)/ENTPD2 maintained hepatocellular carcinoma an immune-suppressive microenvironment Proceeding/Conference:International Liver Cancer Association (ILCA) Annual Conference | 2017 | 82 | ||
Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway Journal:Cell Death & Disease | 2019 | 29 | ||
Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development Journal:Science Advances | 5-May-2023 | |||
2019 | 108 | |||
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD-L1 Journal:Hepatology Communications | 2021 | 18 | ||
2014 | 98 | |||
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses Journal:International Journal of Hepatology | 29-Nov-2022 |